SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001013762-23-007392
Filing Date
2023-10-30
Accepted
2023-10-27 19:27:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ea187412-13deureka_estrella.htm SC 13D 61992
  Complete submission text file 0001013762-23-007392.txt   63739
Mailing Address 5858 HORTON ST STE 170 Emeryville CA 94608
Business Address 5858 HORTON ST STE 170 Emeryville CA 94608 (510) 654-7045
Eureka Therapeutics, Inc. (Filed by) CIK: 0001386560 (see all company filings)

IRS No.: 204354368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 5858 HORTON STREET, SUITE 170 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET, SUITE 170 EMERYVILLE CA 94608 (510) 318-9098
Estrella Immunopharma, Inc. (Subject) CIK: 0001844417 (see all company filings)

IRS No.: 861314502 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92694 | Film No.: 231356925
SIC: 2836 Biological Products, (No Diagnostic Substances)